Glycopeptide antibiotic analogs efficient against vancomycin-resistant bacteria: a patent evaluation (WO2013022763).

about

Glycopeptide antibiotic analogs efficient against vancomycin-resistant bacteria: a patent evaluation (WO2013022763).

Item

http://www.wikidata.org/entity/Q44471668

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Glycopeptide antibiotic analog ...... ent evaluation (WO2013022763).

@en

Glycopeptide antibiotic analog ...... bacteria: a patent evaluation

@nl

type

Item

label

Glycopeptide antibiotic analog ...... ent evaluation (WO2013022763).

@en

Glycopeptide antibiotic analog ...... bacteria: a patent evaluation

@nl

prefLabel

Glycopeptide antibiotic analog ...... ent evaluation (WO2013022763).

@en

Glycopeptide antibiotic analog ...... bacteria: a patent evaluation

@nl

P1476

Glycopeptide antibiotic analog ...... ent evaluation (WO2013022763).

@en

P2093

Eugenia N Olsufyeva

http://www.w3.org/2001/XMLSchema#string

P2860

A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria

Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.

Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.

Glycopeptide and lipoglycopeptide antibiotics.

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands

Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance

Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Locations of the hydrophobic side chains of lipoglycopeptides bound to the peptidoglycan of Staphylococcus aureus

P304

1625-1634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2013.831074

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Q39836898

P577

2013-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23972226

http://www.w3.org/2001/XMLSchema#string